Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The Cross-section Trichometer is a promising tool for measuring hair characteristics without cutting the hair and may have various clinical uses.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Natubiotin is effective for treating different hair loss conditions when used with other therapies.

Platelet-rich plasma shows potential for hair growth, but more research is needed to determine the best preparation method.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

People with alopecia areata often have lower vitamin D levels than healthy people.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

A dermatoscope is important for evaluating hair transplants and managing patient expectations.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

A lotion with minoxidil, hydrocortisone butyrate, and 17a-estradiol can improve or stabilize Frontal Fibrosing Alopecia in some cases, but there's no universally-accepted treatment yet.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Mesotherapy is more effective than topical spray for female hair loss treatment.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Antibody treatments show promise for hair loss but need more research.

LC-OCT helps accurately diagnose different types of infant hair loss without invasive methods.

New treatments for hair loss, like JAK inhibitors, PRP, anti-androgens, and minoxidil, offer better options.

The Scalp Coverage Scoring method reliably measures hair density from images.

SFRP2 and PTGDS may be key factors in female hair loss.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Finasteride-loaded nanoparticles were successfully created for potential improved hair growth treatment.